Chemoinformaics analysis of Genistein 5-glucoside
| Molecular Weight | 432.381 | nRot | 4 |
| Heavy Atom Molecular Weight | 412.221 | nRig | 24 |
| Exact Molecular Weight | 432.106 | nRing | 4 |
| Solubility: LogS | -3.842 | nHRing | 2 |
| Solubility: LogP | -0.254 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 51 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 31 | No. of Aromatic Carbocycles | 2 |
| nHetero | 10 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 21 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 10 | No. of Arom Bond | 17 |
| nHA | 10 | APOL | 56.4259 |
| nHD | 6 | BPOL | 26.1401 |
| QED | 0.331 |
| Synth | 3.876 |
| Natural Product Likeliness | 2.019 |
| NR-PPAR-gamma | 0.604 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.764 |
| HIA | 0.613 |
| CACO-2 | -6.221 |
| MDCK | 0.0000431 |
| BBB | 0.183 |
| PPB | 0.85068 |
| VDSS | 0.898 |
| FU | 0.149202 |
| CYP1A2-inh | 0.059 |
| CYP1A2-sub | 0.04 |
| CYP2c19-inh | 0.022 |
| CYP2c19-sub | 0.056 |
| CYP2c9-inh | 0.012 |
| CYP2c9-sub | 0.673 |
| CYP2d6-inh | 0.139 |
| CYP2d6-sub | 0.254 |
| CYP3a4-inh | 0.055 |
| CYP3a4-sub | 0.023 |
| CL | 3.358 |
| T12 | 0.564 |
| hERG | 0.047 |
| Ames | 0.318 |
| ROA | 0.094 |
| SkinSen | 0.074 |
| Carcinogencity | 0.572 |
| EI | 0.018 |
| Respiratory | 0.023 |
| NR-Aromatase | 0.642 |
| Antiviral | Yes |
| Prediction | 0.894738 |